MAP2K1 and cancer: Furthermore, IHC staining showed that Ki-67, p-ERK1/2 and p-MEK1/2 in the erianin and combination therapy group significantly decreased compared with the vehicle group in SK-MEL-2, A375, and HCT116 cancer tissues (Fig. 5e, Supplementary Fig. S6c).